Day Zero Diagnostics, Inc (a bioMérieux Company) Employee Directory

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Day Zero Diagnostics, based in Boston, Massachusetts, operates in the medical equipment manufacturing sector and focuses on advancing infectious disease diagnostics through genome sequencing. The company aims to generate clinically actionable information at scale by applying whole-genome sequencing and supporting technologies to clinical samples, including methods to enrich pathogen DNA and analytical work that translates data into diagnostic results, backed by a database of genome sequences and antimicrobial efficacy profiles. By doing so, Day Zero seeks to transform how infectious diseases are tracked, managed, and treated in real time.

Initially, the company targets bloodstream infections and sepsis, addressing a clinical window where rapid, precise identification of pathogens and their antibiotic susceptibilities is critical. It is a smaller enterprise operating in the Boston area, bridging medical devices with genomic informatics. In 2025, bioMérieux announced the acquisition of Day Zero Diagnostics, reflecting its integration into a larger corporate portfolio.

Sign up for free to view info

Company overview Email format